Results 291 to 300 of about 348,393 (352)

P-1517. Assessing the novel combinations against Carbapenem resistant Acinetobacter baunmannii (CRAB): ceftazidime-avibactam and ampicillin-sulbactam

open access: gold
Vyanka Mezcord   +8 more
openalex   +1 more source

Prolonged exposure to teixobactin generates cross-tolerance to other cell wall-targeting antimicrobials in <i>Enterococcus faecalis</i>. [PDF]

open access: yesAntimicrob Agents Chemother
Darnell RL   +10 more
europepmc   +1 more source

The rising threat of antibiotic and multidrug resistance in neonatal urinary tract infections. [PDF]

open access: yesBMC Pediatr
Sağlam MK   +6 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Ampicillin in mares: A comparison of intramuscular sodium ampicillin or sodium ampicillin-ampicillin trihydrate injection

American Journal of Veterinary Research, 1982
SUMMARY A cross-over experiment was used to compare serum ampicillin concentrations in mares. Six mares and 2 dose regimens were used. Four of 6 mares were in midterm of gestation; the remaining 2 were not pregnant. Ampicillin was injected im and was administered every 12 hours for 3 doses. Dose regimens compared were sodium ampicillin (22 mg/kg) given
D S, Traver, J E, Riviere
openaire   +2 more sources

Ampicillin and Shigellosis

Archives of Pediatrics & Adolescent Medicine, 1973
To the Editor. —In the October issue of theJournalwe reported a study of shigellosis in outpatients conducted in 1969 and 1970 demonstrating the bacteriological and clinical effectiveness of ampicillin. 1 This work confirmed previously reported observations of effectiveness made in hospitalized children with severe shigellosis.
openaire   +2 more sources

Ampicillin Rashes

Pediatrics, 1977
Ampicillin is generally considered the drug of choice in the treatment of otitis media in children under age 5.1 For this and other reasons it has become a frequently prescribed and yet still effective drug. The maculopapular rash that often accompanies its use is well known.
openaire   +2 more sources

Sulbactam / Ampicillin

Infection Control and Hospital Epidemiology, 1988
Sulbactam/ampicillin was recently marketed for use in several infections caused by beta-lactamase-producing organisms. Sulbactam is the second beta-lactamase inhibitor to become available in the United States. Interest in inhibition of beta-lactamases arose in the late 1960s when a combination consisting of an antibacterial agent and an enzyme ...
openaire   +1 more source

Home - About - Disclaimer - Privacy